UBS Group’s Aphria Inc. Common Shares APHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-250,205
Closed -$4.6M 10366
2021
Q1
$4.6M Buy
250,205
+238,603
+2,057% +$3.87M ﹤0.01% 2702
2020
Q4
$81K Sell
11,602
-16,617
-59% -$104K ﹤0.01% 5832
2020
Q3
$125K Buy
28,219
+8,390
+42% +$39.2K ﹤0.01% 5060
2020
Q2
$85K Sell
19,829
-9,919
-33% -$38K ﹤0.01% 5430
2020
Q1
$91K Buy
29,748
+27,523
+1,237% +$110K ﹤0.01% 5372
2019
Q4
$12K Sell
2,225
-21,666
-91% -$106K ﹤0.01% 7210
2019
Q3
$124K Sell
23,891
-4,068
-15% -$25.8K ﹤0.01% 5628
2019
Q2
$196K Buy
27,959
+9,167
+49% +$69.3K ﹤0.01% 4927
2019
Q1
$176K Buy
18,792
+13,775
+275% +$121K ﹤0.01% 4694
2018
Q4
$28K Buy
+5,017
New +$39.5K ﹤0.01% 6545

UBS Group's APHA Position: Q2 2021 in Review

UBS Group sold out of Aphria Inc. Common Shares (APHA) in Q2 2021, closing a stake of 250,205 shares — an estimated $4.6M sold.

UBS Group first reported a position in APHA in Q4 2018 and held it in 10 quarters. The position peaked at $4.6M in Q1 2021. 0 funds tracked by Wall St. Rank hold APHA as of Q2 2021.

  • UBS Group reported no remaining Aphria Inc. Common Shares position as of Q2 2021 after selling out during the quarter.
  • UBS Group sold 250,205 Aphria Inc. Common Shares shares in Q2 2021, an estimated $4.6M.
  • UBS Group first reported a position in Aphria Inc. Common Shares in Q4 2018 and held it in 10 quarters.
  • UBS Group's Aphria Inc. Common Shares position peaked at $4.6M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Aphria Inc. Common Shares as of Q2 2021.

Based on UBS Group's 13F filing for Q2 2021, filed 13 Aug 2021.